The impact of PET/CT in the management of recurrent ovarian cancer.
about
Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.A Case Report Demonstrating Unambiguous Clinical Utility of Pet/CT Scanning in Recurrent Ovarian CancerMetabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR SpectroscopyThe role of FDG-PET/CT in gynaecological cancers.Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patientsVolume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.Staging recurrent ovarian cancer with (18)FDG PET/CT.Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival.Detecting peritoneal dissemination of ovarian cancer in mice by DWIBSPET and PET-CT imaging of gynecological malignancies: present role and future promise.Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.Present and future of FDG-PET/CT in ovarian cancer.Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach.Molecular imaging for personalized cancer care.Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer.Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography.The role of 18F-FDG PET CT in common gynaecological malignancies.Diagnostic value of positron emission tomography (PET) and PET/computed tomography in recurrent/metastatic ovarian cancer: A meta-analysis.
P2860
Q30444706-77EE2754-8275-4295-8F48-525967FDF5BEQ34054796-FCD39C30-6966-4AED-AEDA-C6F9C70453ADQ34960082-2379B883-FFAE-4E35-9720-F80409456462Q35909482-8D21074C-D4B0-454C-9999-7D50305FA0DAQ36029023-DC661639-EC51-4908-9B83-1811E372E60BQ36132602-891FAACF-9111-46A1-A730-467DBCA3215BQ36611758-A70A6F19-D045-4F50-BF47-7FC6A197E371Q37053323-9CA805C4-C26C-440B-8C2F-4BBB51E98087Q37088989-F3FD0E46-7DF8-440A-B25C-2AF7C1985DEBQ37357297-4617DEFA-871D-4294-8139-EE97D1A751CEQ37644820-D4528D36-6C06-4C90-91FF-C7C37F22218DQ37767364-78EA8AE6-0D12-488A-B371-E72B35E10AD9Q37813044-5D3B1389-A3CE-405F-881D-7D2BA3C90594Q37989180-B17C0792-2994-4963-BB2A-27D73C257C96Q37999206-76CE44C6-23AA-4FE1-9322-0E8734505F2BQ38162103-91FCF0C1-2002-4E6B-AA15-141CD75BA811Q46635769-8BE8711C-72EA-4C82-9357-88D53CF00A58Q52936161-25BD0515-6950-4116-8C13-5C4B3A4DD574Q52953075-133DDF99-29A5-4B2C-8948-5E1DE1053869
P2860
The impact of PET/CT in the management of recurrent ovarian cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The impact of PET/CT in the management of recurrent ovarian cancer.
@en
The impact of PET/CT in the management of recurrent ovarian cancer.
@nl
type
label
The impact of PET/CT in the management of recurrent ovarian cancer.
@en
The impact of PET/CT in the management of recurrent ovarian cancer.
@nl
prefLabel
The impact of PET/CT in the management of recurrent ovarian cancer.
@en
The impact of PET/CT in the management of recurrent ovarian cancer.
@nl
P2093
P1433
P1476
The impact of PET/CT in the management of recurrent ovarian cancer.
@en
P2093
Alvin Milner
Bryony Simcock
Deborah Neesham
Elisabeth Drummond
P304
P356
10.1016/J.YGYNO.2006.03.004
P407
P577
2006-04-19T00:00:00Z